BG104105A - Алатрофлоксацинови парентерални състави - Google Patents

Алатрофлоксацинови парентерални състави Download PDF

Info

Publication number
BG104105A
BG104105A BG104105A BG10410500A BG104105A BG 104105 A BG104105 A BG 104105A BG 104105 A BG104105 A BG 104105A BG 10410500 A BG10410500 A BG 10410500A BG 104105 A BG104105 A BG 104105A
Authority
BG
Bulgaria
Prior art keywords
compound
formula
impurities
pharmaceutically acceptable
parenteral composition
Prior art date
Application number
BG104105A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Guinn
John Lambert
Subramanian GUHAN
Stanley WALINSKY
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG104105A publication Critical patent/BG104105A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG104105A 1997-08-01 2000-01-25 Алатрофлоксацинови парентерални състави BG104105A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01
PCT/IB1998/001122 WO1999006430A1 (fr) 1997-08-01 1998-07-23 Compositions a base d'alatrofloxacine, administrables par voie parenterale

Publications (1)

Publication Number Publication Date
BG104105A true BG104105A (bg) 2000-08-31

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104105A BG104105A (bg) 1997-08-01 2000-01-25 Алатрофлоксацинови парентерални състави

Country Status (40)

Country Link
US (1) US6194429B1 (fr)
EP (1) EP1000086B1 (fr)
JP (1) JP3463928B2 (fr)
KR (1) KR20010022495A (fr)
CN (1) CN1265671A (fr)
AP (1) AP1031A (fr)
AR (1) AR015417A1 (fr)
AT (1) ATE259827T1 (fr)
AU (1) AU734863B2 (fr)
BG (1) BG104105A (fr)
BR (1) BR9811580A (fr)
CA (1) CA2296466C (fr)
CO (1) CO4970688A1 (fr)
DE (1) DE69821767T2 (fr)
DK (1) DK1000086T3 (fr)
DZ (1) DZ2576A1 (fr)
EA (1) EA002120B1 (fr)
ES (1) ES2214716T3 (fr)
GT (1) GT199800112A (fr)
HN (1) HN1998000106A (fr)
HR (1) HRP980417B1 (fr)
HU (1) HUP0004793A3 (fr)
ID (1) ID24374A (fr)
IL (1) IL134156A0 (fr)
IS (1) IS5339A (fr)
MA (1) MA24626A1 (fr)
NO (1) NO20000485L (fr)
NZ (1) NZ502249A (fr)
OA (1) OA11281A (fr)
PA (1) PA8456701A1 (fr)
PE (1) PE103799A1 (fr)
PL (1) PL338477A1 (fr)
PT (1) PT1000086E (fr)
SK (1) SK1012000A3 (fr)
TN (1) TNSN98146A1 (fr)
TW (1) TW538043B (fr)
UY (1) UY25113A1 (fr)
WO (1) WO1999006430A1 (fr)
YU (1) YU2500A (fr)
ZA (1) ZA986874B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230030B1 (hu) * 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
EP1121933A1 (fr) * 2000-02-02 2001-08-08 Pfizer Products Inc. Compositions prémélangées injectables d'alatrofloxacin
EP1560584B1 (fr) 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Inhibiteurs de fab i
EP1575951B1 (fr) * 2002-12-06 2014-06-25 Debiopharm International SA Composes heterocycliques, procedes de production de ceux-ci et utilisation de ceux-ci dans un traitement
WO2004082586A2 (fr) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Compositions comportant plusieurs agents antibiotiques, et leurs procedes de mise en oeuvre
CA2467321A1 (fr) * 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
DK1828167T3 (da) * 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (fr) 2007-02-16 2014-08-20 Debiopharm Int Sa Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
AU2013279021C1 (en) 2012-06-19 2017-03-16 Debiopharm International Sa Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
JP6702883B2 (ja) * 2014-04-25 2020-06-03 ノーレックス インコーポレイテッド 向神経活性ペプチドの安定な組成物
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
CN111971292B (zh) 2018-02-02 2024-12-13 波纹疗法公司 包含类固醇二聚体的玻璃制剂及其用途
WO2020154815A1 (fr) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Formes cristallines de dimères de dexaméthasone et leurs utilisations
TN2021000159A1 (en) 2019-02-14 2023-04-04 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
SG11202113174SA (en) 2019-06-14 2021-12-30 Debiopharm Int Sa Medicament and use thereof for treating bacterial infections involving biofilm
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
WO2021220061A2 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions hétérodimères et méthodes pour le traitement de troubles oculaires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
CZ286896B6 (en) 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
DK0789697T3 (da) 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
DE69622715T2 (de) * 1995-06-15 2002-11-14 Pfizer Inc., New York Verfahren zur herstellung von derivaten der ein peptid enthaltenden azabizylo-naphtyridin-carbonsäure
US6080756A (en) * 1995-08-29 2000-06-27 Pfizer Inc. Polymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacin
WO1997007800A1 (fr) 1995-08-29 1997-03-06 Pfizer Inc. Formes zwitterioniques de trovafloxacine
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
PT1000086E (pt) 2004-05-31
MA24626A1 (fr) 1999-04-01
DZ2576A1 (fr) 2003-02-22
HUP0004793A2 (hu) 2001-04-28
DE69821767T2 (de) 2005-01-13
JP3463928B2 (ja) 2003-11-05
CN1265671A (zh) 2000-09-06
JP2001512133A (ja) 2001-08-21
DE69821767D1 (de) 2004-03-25
HRP980417B1 (en) 2002-10-31
HRP980417A2 (en) 1999-08-31
HUP0004793A3 (en) 2001-10-29
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
BR9811580A (pt) 2000-08-22
UY25113A1 (es) 2000-12-29
NO20000485D0 (no) 2000-01-31
ATE259827T1 (de) 2004-03-15
NZ502249A (en) 2001-11-30
EP1000086A1 (fr) 2000-05-17
AR015417A1 (es) 2001-05-02
CO4970688A1 (es) 2000-11-07
HN1998000106A (es) 1999-01-08
AU734863B2 (en) 2001-06-21
SK1012000A3 (en) 2000-09-12
CA2296466A1 (fr) 1999-02-11
ZA986874B (en) 2000-01-31
KR20010022495A (ko) 2001-03-15
AU8236898A (en) 1999-02-22
OA11281A (en) 2002-11-19
YU2500A (sh) 2002-09-19
ES2214716T3 (es) 2004-09-16
WO1999006430A1 (fr) 1999-02-11
EP1000086B1 (fr) 2004-02-18
DK1000086T3 (da) 2004-05-17
IL134156A0 (en) 2001-04-30
EA200000086A1 (ru) 2000-08-28
AP9801310A0 (en) 1998-09-30
NO20000485L (no) 2000-03-27
PE103799A1 (es) 1999-10-25
TNSN98146A1 (fr) 2005-03-15
AP1031A (en) 2001-12-21
GT199800112A (es) 2000-01-15
IS5339A (is) 2000-01-14
ID24374A (id) 2000-07-13
US6194429B1 (en) 2001-02-27
CA2296466C (fr) 2003-04-15
EA002120B1 (ru) 2001-12-24
PA8456701A1 (es) 2000-05-24

Similar Documents

Publication Publication Date Title
BG104105A (bg) Алатрофлоксацинови парентерални състави
CN111225665A (zh) 大环免疫调节剂
JP3145715B2 (ja) 無水７−（［１α，５α，６α］−６−アミノ−３−アザビシクロ［３．１．０］ヘキサ−３−イル）−６−フルオロ−１−（２，４−ジフルオロフェニル）−１，４−ジヒドロ−４−オキソ−１，８−ナフチリディン−３−カルボン酸メタンスルホン酸塩の新規な結晶形態
CN118715205A (zh) 用于治疗与sting活性相关的病症的化合物和组合物
EP0847400B1 (fr) Polymorphes du promedicament 6-n-(l-ala-l-ala)-trovafloxacine
MXPA00001142A (en) Alatrofloxacin parenteral compositions
CN118459472A (zh) 一种异喹啉生物碱类化合物及其制备方法和应用
HK1027361A (en) Alatrofloxacin parenteral compositions
CN118451090A (zh) 一种酰胺类抗病毒化合物
JPH04198185A (ja) イソチアゾロ〔５，４―ｂ〕ピリジン誘導体
CZ2000224A3 (cs) Alatrofloxacinové paranterální kompozice
MXPA98001665A (en) Polymorphoses of profarmaco of 6-n- (l-ala-l-ala) -trovafloxacin, procedure for its preparation and use of mis